Skip to main content
OpenTrials

Clinical trial condition

Pneumonia, Pneumococcal

Explore clinical trials studying Pneumonia, Pneumococcal. Study availability and eligibility vary by location and protocol.

35 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Pneumonia, Pneumococcal trial results

Completed

Pneumococcal Community-Acquired Pneumonia Requiring Hospitalization Among Colombian Adults

NCT07354425

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Community Acquired Pneumonia (CAP), +13 more
Locations
  • Clinica de Marly Jorge Cavelier Gaviria SAS Chía, Cundinamarca, Colombia
  • Clinica Universidad de La Sabana Chía, Cundinamarca, Colombia
  • ESE Hospital San Antonio de Chia Chía, Cundinamarca, Colombia
  • Centro Medico San Luis Clinica Quirurgica SAS Cajicá, Colombia
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 When Administered Concomitantly With Influenza Vaccine in Adults 50 Years of Age or Older (V116-005, STRIDE-5)

NCT05526716

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +9 more
Locations
  • Central Phoenix Medical Clinic-Synexus Clinical Research US ( Site 0012) Phoenix, Arizona, United States
  • Hope Clinical Research, Inc. ( Site 0070) Canoga Park, California, United States
  • Paradigm Clinical Research Centers, Inc ( Site 0024) La Mesa, California, United States
  • Catalina Research Institute, LLC ( Site 0067) Montclair, California, United States
View all 56 locations
View Trial Details
Completed

A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants

NCT05412030

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +9 more
Locations
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Pensacola, Florida, United States
View all 46 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)

NCT05420961

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +9 more
Locations
  • Central Research Associates ( Site 0024) Birmingham, Alabama, United States
  • Lenzmeier Family Medicine/CCT Research ( Site 0008) Glendale, Arizona, United States
  • Fiel Family and Sports Medicine, PC/CCT Research ( Site 0006) Tempe, Arizona, United States
  • Southland Clinical Research Center ( Site 0026) Fountain Valley, California, United States
View all 51 locations
View Trial Details

Related conditions